Anticancer agent 262
Anticancer agent 262 (compound 3h) is a DNA intercalating anticancer agent, with an IC50 of 5.7 µM against A549 cancer cells[1].
Product Specifications
UNSPSC
12352005
Target
DNA/RNA Synthesis
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
CC(C(C)=C1)=CC2=C1N=C(/C=C/C3=CC=CC=C3)C=C2C(NCCN(CC)CC)=O
Molecular Formula
C26H31N3O
Molecular Weight
401.54
References & Citations
[1]Negar Omidkhah, et al. Design, synthesis, biological evaluation and multi spectroscopic studies of novel 2-styrylquinoline-carboxamide derivatives as potential DNA intercalating anticancer agents. Bioorg Chem. 2025 Jan:154:108098.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NB500-496AF405 0.1 mL
Mouse Monoclonal Integrin alpha 2b/CD41 Antibody (IVA30) [Alexa Fluor 405]
Ask
View Details